Global identification of phospho-dependent SCF substrates reveals a FBXO22 phosphodegron and an ERK-FBXO22-BAG3 axis in tumorigenesis

SKP1-CUL1-F-box (SCF) ubiquitin ligases play fundamental roles in cellular functions. Typically, substrate phosphorylation is required for SCF recognition and subsequent degradation. However, phospho-dependent substrates remain largely unidentified. Here, using quantitative phoshoproteome approach,...

Full description

Saved in:
Bibliographic Details
Published inCell death and differentiation Vol. 29; no. 1; pp. 1 - 13
Main Authors Liu, Ping, Cong, Xiaoji, Liao, Shengjie, Jia, Xinglong, Wang, Xiaomin, Dai, Wei, Zhai, Linhui, Zhao, Lei, Ji, Jing, Ni, Duan, Liu, Zhiwei, Chen, Yulu, Pan, Lulu, Liu, Wei, Zhang, Jian, Huang, Min, Liu, Bin, Tan, Minjia
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.01.2022
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:SKP1-CUL1-F-box (SCF) ubiquitin ligases play fundamental roles in cellular functions. Typically, substrate phosphorylation is required for SCF recognition and subsequent degradation. However, phospho-dependent substrates remain largely unidentified. Here, using quantitative phoshoproteome approach, we performed a system-wide investigation of phospho-dependent SCF substrates. This strategy identified diverse phospho-dependent candidates. Biochemical verification revealed a mechanism by which SCF FBXO22 recognizes the motif XXPpSPXPXX as a conserved phosphodegron to target substrates for destruction. We further demonstrated BAG3, a HSP70 co-chaperone, is a bona fide substrate of SCF FBXO22 . FBXO22 mediates BAG3 ubiquitination and degradation that requires ERK-dependent BAG3 phosphorylation at S377. FBXO22 depletion or expression of a stable BAG3 S377A mutant promotes tumor growth via defects in apoptosis and cell cycle progression in vitro and in vivo. In conclusion, our study identified broad phosphorylation-dependent SCF substrates and demonstrated a phosphodegron recognized by FBXO22 and a novel ERK-FBXO22-BAG3 axis involved in tumorigenesis.
ISSN:1350-9047
1476-5403
DOI:10.1038/s41418-021-00827-7